Nonalcoholic Fatty Liver Disease and Endocrine Axes-A Scoping Review

• Tipo: Outra Publicação em Revista Científica Internacional
• Data: 2022

Autores

Von-Hafe, M (Autor) Outra; Borges-Canha, M (Autor) FMUP; Vale, C (Autor) FMUP; Leite, AR (Autor) Outra; Neves, JS (Autor) FMUP; Carvalho, Davide (Autor) FMUP; Leite-Moreira AF (Autor) FMUP

Revista

Título: Metabolites

Vol. 12

Página Final: 298

ISSN: 2218-1989

Editora: MDPI

Indexação

ISI Web of Knowledge - 18 Citações

Scopus - 4 Citações

Outras Informações

ID Authenticus: P-00W-AQX

DOI: 10.3390/metabo12040298

Abstract (EN): Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. NAFLD often occurs associated with endocrinopathies. Evidence suggests that endocrine dysfunction may play an important role in NAFLD development, progression, and severity. Our work aimed to explore and summarize the crosstalk between the liver and different endocrine organs, their hormones, and dysfunctions. For instance, our results show that hyperprolactinemia, hypercortisolemia, and polycystic ovary syndrome seem to worsen NAFLD's pathway. Hypothyroidism and low growth hormone levels also may contribute to NAFLD's progression, and a bidirectional association between hypercortisolism and hypogonadism and the NAFLD pathway looks likely, given the current evidence. Therefore, we concluded that it appears likely that there is a link between several endocrine disorders and NAFLD other than the typically known type 2 diabetes mellitus and metabolic syndrome (MS). Nevertheless, there is controversial and insufficient evidence in this area of knowledge.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 30